BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mohan S, Patel S, Greenstein I, Ng C, Frazier K, Nguyen G, Harding L, Barlow D. Metabolic relevance for N-hydroxy L-arginine reduction in estrogen-negative breast cancer cells. Amino Acids 2018;50:1629-36. [PMID: 29922922 DOI: 10.1007/s00726-018-2603-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Mohan S, Lawton R, Palmer C, Rojas AC. Competitive ELISA method for novel estrogen-negative breast cancer biomarker quantitation. Journal of Immunological Methods 2019;474:112671. [DOI: 10.1016/j.jim.2019.112671] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 Arral ML, Tooley C, Ziino E, Halpern JM. Elucidating the Electrochemical Mechanism of NG-Hydroxy-L-arginine. J Electrochem Soc 2020;167. [PMID: 32095022 DOI: 10.1149/1945-7111/ab643a] [Reference Citation Analysis]
3 Bollenbach A, Bakker SJL, Tsikas D. GC-MS measurement of biological NG-hydroxy-L-arginine, a stepmotherly investigated endogenous nitric oxide synthase substrate and arginase inhibitor. Amino Acids 2019;51:627-40. [PMID: 30610471 DOI: 10.1007/s00726-018-02695-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Mohan S, Patel S, Barlow D, Rojas AC. Assessing the predictive response of a simple and sensitive blood-based biomarker between estrogen-negative solid tumors. Adv Med Sci 2020;65:424-8. [PMID: 32919119 DOI: 10.1016/j.advms.2020.08.004] [Reference Citation Analysis]
5 Bollenbach A, Hanff E, Tsikas D. Investigation of NG-hydroxy-l-arginine interference in the quantitative determination of nitrite and nitrate in human plasma and urine by GC-NICI-MS. Journal of Chromatography B 2018;1100-1101:174-8. [DOI: 10.1016/j.jchromb.2018.10.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]